
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 301692-76-2 |
| Catalog No. | 2A-9093664 |
| Chinese Name | Polmacoxib |
| Synonyms | 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide |
| Molecular Formula | C18H16FNO4S |
| Molecular Weight | 361.39 |
| Purity | ≥98 (HPLC) |
| Appearance | powder |
| Storage Condition | 2-8°C, dry, sealed |
| Application | Polmacoxib (CG100649) is a first-in-class orally active non-steroidal anti-inflammatory drug (NSAID) and a dual inhibitor of COX-2 (IC50 is approximately 0.1 μg/ml) and carbonic anhydrase [1]. Polmaco |
| PubChem ID | 14803465 |
| MDL Number | MFCD22570958 |
| SMILES | NS(C1=CC=C(C=C1)C(OC2(C)C)=C(C2=O)C3=CC=CC(F)=C3)(=O)=O |
| InChI | 1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23) |
| InChI Key | IJWPAFMIFNSIGD-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 51111800 |
| MSDS | msds/93664_1_301692_76_2.pdf |
| Transport Info | Product Name: Parmacoxib |
| Related Products in Heterocyclic Building Blocks | ||
|---|---|---|
| 2,5-Bis(trifluoromethyl)pyridine | 20857-44-7 | 2A-9093557 |
| 4-bromo-1H-pyrrolo[2,3-c]pyridine | 69872-17-9 | 2A-9093594 |
| 5-bromobenzo[b]thiophene-2,3-dione | 50891-90-2 | 2A-9093610 |
| 2-Bromo-5-methyl-3-(trifluoromethyl)pyridine | 65996-08-9 | 2A-9093643 |
| ascofuranone | 38462-04-3 | 2A-9093649 |
| 1,3-dioxolane-2-propylamine | 4388-60-7 | 2A-9093689 |
| 3-(2-PYRIDYL)-5,6-DIPHENYL-1,2,4-TRIAZINE | 1046-56-6 | 2A-9093694 |
| 3-Pyridinethiol,6-(dimethylamino)-(9CI) | 680591-10-0 | 2A-9093699 |
| 3,3-Diethyl-2,4-azetidinedione | 42282-85-9 | 2A-9093739 |
| 2,2,3,3,4,4,5-Heptafluoro-5-(heptafluoropropyl)tetrahydrofuran | 423-22-3 | 2A-9093768 |
| Browse all Heterocyclic Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA